APA (7th ed.) Citation

S, S., LF, D., P, C., MM, K., K, D., R, M., . . . GA, R. (2026). Additive Effects of Dorzagliatin and Glucagon-Like Peptide 1 Receptor Agonism in a Novel Mouse Model of GCK-MODY and in Obese db/db Mice. Diabetes, 75(1), 99. https://doi.org/10.2337/db25-0520

Chicago Style (17th ed.) Citation

S, Salazar, et al. "Additive Effects of Dorzagliatin and Glucagon-Like Peptide 1 Receptor Agonism in a Novel Mouse Model of GCK-MODY and in Obese Db/db Mice." Diabetes 75, no. 1 (2026): 99. https://doi.org/10.2337/db25-0520.

MLA (9th ed.) Citation

S, Salazar, et al. "Additive Effects of Dorzagliatin and Glucagon-Like Peptide 1 Receptor Agonism in a Novel Mouse Model of GCK-MODY and in Obese Db/db Mice." Diabetes, vol. 75, no. 1, 2026, p. 99, https://doi.org/10.2337/db25-0520.